Sunday, January 04, 2015 7:20:46 AM
I must say, I think this has alot of us scraching our heads. Did Nanosomix beat us to market with their 96% accurate p-tau blood test?
Why is this the first time we have heard of this?
I would have thought that Jason N would have mentioned this as he seems to be quick to point out any hurdles AMBS might face.
From the Nanosomix PR in Sept-
Quote:
--------------------------------------------------------------------------------
Our first blood assay will be available this fall for researchers and pharmaceutical companies that want to use p-tau as a biomarker for drug evaluation or patient sample enrichment in their clinical trials,”
--------------------------------------------------------------------------------
After re-reading the last chairmans blog after the "launch" of LYMPRO, I noticed that there was not any mention of " the first AD blood test on the market" only AMBS launches "their" first product.
http://www.thechairmansblog.com/amarantus-bio...cs-market/
I am waiting patiently to hear what CG presents on Jan 14th.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM